Reported about 1 year ago
Pfizer announced that Chief Scientific Officer Mikael Dolsten, instrumental in developing the COVID-19 vaccine, will resign after over 15 years at the company. Dolsten, 65, led Pfizer's research and development, overseeing the successful launch of the Comirnaty vaccine and other major products. Pfizer is now seeking a successor as it faces declining COVID product sales and implements cost-cutting measures to reduce expenses by $1.5 billion by 2027.
Source: YAHOO